Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 8/2020

01-12-2020 | Original Article

Robotic resection for benign primary retroperitoneal tumors via the transperitoneal approach

Authors: Ronggui Lin, Xianchao Lin, Fengchun Lu, Yuanyuan Yang, Congfei Wang, Haizong Fang, Yanchang Chen, Heguang Huang

Published in: Langenbeck's Archives of Surgery | Issue 8/2020

Login to get access

Abstract

Background

Surgical resection is the primary treatment for benign primary retroperitoneal tumors. However, only a few studies have reported robotic resection for retroperitoneal tumors due to the low morbidity rate, and only a small fraction of retroperitoneal tumors are eligible for minimally invasive operations.

Methods

A retrospective study enrolling 16 patients with benign primary retroperitoneal tumors between November 2016 and April 2020 was conducted to evaluate the efficacy of robotic resection for benign primary retroperitoneal tumors via the transperitoneal approach. Surgical skills were described in detail and operative experiences were summarized.

Results

The operations were uneventfully performed without conversion in all the patients. The median operation time was 135 (120–180) min, and the median estimated blood loss was 25 (20–60) mL. The median duration of diet restoration was 2 (1–2) days and the median length of postoperative hospital stay was 6 (4–7) days. No serious intraoperative or postoperative complications occurred during the perioperative period.

Conclusions

Robotic resection via the transperitoneal approach is a feasible and safe procedure for highly selected patients with benign primary retroperitoneal tumors, with few postoperative complications and a rapid recovery.
Appendix
Available only for authorised users
Literature
2.
go back to reference Dayan D, Abu-Abeid S, Kuriansky J, Lahat G, Sagie B (2020) Rare primary retroperitoneal neoplasms. Isr Med Assoc J 22(1):53–59PubMed Dayan D, Abu-Abeid S, Kuriansky J, Lahat G, Sagie B (2020) Rare primary retroperitoneal neoplasms. Isr Med Assoc J 22(1):53–59PubMed
5.
go back to reference Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI (2019) Role of radiation therapy for retroperitoneal sarcomas: an eight-institution study from the US Sarcoma Collaborative. J Surg Oncol 120(7):1227–1234. https://doi.org/10.1002/jso.25694CrossRefPubMedPubMedCentral Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI (2019) Role of radiation therapy for retroperitoneal sarcomas: an eight-institution study from the US Sarcoma Collaborative. J Surg Oncol 120(7):1227–1234. https://​doi.​org/​10.​1002/​jso.​25694CrossRefPubMedPubMedCentral
13.
Metadata
Title
Robotic resection for benign primary retroperitoneal tumors via the transperitoneal approach
Authors
Ronggui Lin
Xianchao Lin
Fengchun Lu
Yuanyuan Yang
Congfei Wang
Haizong Fang
Yanchang Chen
Heguang Huang
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 8/2020
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-020-01961-5

Other articles of this Issue 8/2020

Langenbeck's Archives of Surgery 8/2020 Go to the issue